The MEDRAD Avanta Fluid Management Injection System and Vanguard Dx Angiographic Catheters give clinicians a single, flexible system for virtually all cardiovascular imaging procedures.

The Aquilion 64 CFX features advanced multidetector CT imaging technology and is currently being validated in the industry’s first international, multicenter trial, CorE 64.

The Dual Screen Vmax Encore allows for safe and complete monitoring of a stress test.
VIASYS has combined the GE Marquette 12-lead ECG software with an exercise metabolic cart. This system provides the ability to measure oxygen uptake, carbon dioxide production, respiratory rate, ventilation and many other parameters while watching the 12-lead ECG monitoring system. It also differentiates between muscular, respiratory and cardiovascular disease with gas exchange features. CPT codes are available for the reimbursement of these extra diagnostic parameters.

The RadiForce G33 is a 3MP monochrome LCD monitor designed for accurate diagnosis in medical imaging applications including PACS, chest radiology, CT, MRI and angiography. It has a 10-bit (1,021 tones) simultaneous grayscale display capability from a palette of 3,061 tones for high-definition medical imaging. Featuring a 23.3-inch screen, the monitor has a 13-bit look-up table that produces a palette of 8,161 grayscale tones from which 4,096 can be displayed simultaneously.

An intraoperative fluorescent imaging system, SPY technology, enables cardiac surgeons to confirm the location of the coronary arteries and assess bypass graft functionality during coronary artery bypass procedures.
Patented by Novadaq Technologies, the SPY Imaging System enables the surgeon to view, record, replay, print and archive high-quality, real-time images of the coronary arteries and bypass grafts.

The angiography and X-ray division of Siemens Medical Solutions will showcase its AXIOM Artis imaging system with 30 by 40 cm configuration for cardiology.

The FDA has approved revised labeling for the instructions for use of the CYPHER Sirolimus-eluting Coronary Stent. The labeling now reflects FDA's review of clinical trial data that suggests there is no increased risk of myocardial infarction with the use of overlapping CYPHER Stents in comparison to bare metal stents.

A new contestant in the $115-million global heart valve repair market, the ATS Simulus annuloplasty line of products by ATS Medical was cleared for release by the FDA at the end of January. Designed with input from cardiac surgeons, the devices emphasize ease of implantation.
Available in a flexible ring (the ATS Simulus FLX-O Ring) or a flexible band (the ATS Simulus FLX-C Band), the products accommodate various approaches to valve repair. They can be used in both the mitral and tricuspid position.

A new percutaneous transluminal angioplasty balloon catheter, the Advance ATB PTA Dilatation Catheter by Cook is designed for optimal ease of insertion and pullback into the sheath.
Responding to the needs of physicians performing numerous dilatation procedures, the Advance balloon incorporates an increased lumen size for faster inflation/deflation rates while still providing sufficient rated burst pressure to dilate demanding lesions.

The Elecsys proBNP assay is the first and only natriuretic peptide test to receive FDA clearance for the risk assessment of cardiac events in people who have stable coronary artery disease — nearly 13 million in the U.S.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now